2 citations
,
June 2003 in “PubMed” The two finasteride formulations are bioequivalent.
January 2012 in “Pharmacy Today” This study concluded that two formulations of finasteride were bioequivalent based on Cmax, AUC, and Tmax data from healthy volunteers.
January 2006 in “The Chinese Journal of Modern Applied Pharmacy” In this study, researchers developed a sensitive HPLC-MS method to measure finasteride in plasma, and found that its pharmacokinetics vary widely among healthy volunteers after taking a 5mg oral dose.
This study established an HPLC-MS method for measuring oxymatrine in human plasma and used it to examine the pharmacokinetics of its capsules.
January 2005 in “Yaowu fenxi zazhi” This study concluded that domestic and imported finasteride tablets are bioequivalent, with no significant differences in their pharmacokinetics among healthy volunteers.